Alessandra M. Rosini
Uberlandia, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Anti-Toxoplasma gondii activity of two novel synthetic compounds based on pyridine, benzimidazole and benzoxazole scaffolds in human maternal-fetal interface models.
Journal: Microbial pathogenesis
Published: April 14, 2026
Brazilian Red Propolis and Its Active Constituent 7-O-methylvestitol Impair Early and Late Stages of Toxoplasma gondii Infection in Human Placental Models.
Journal: Microorganisms
Published: June 30, 2025
Insights into the Role of Proteolytic and Adhesive Domains of Snake Venom Metalloproteinases from Bothrops spp. in the Control of Toxoplasma gondii Infection.
Journal: Toxins
Published: December 14, 2024
MjTX-II, a Lys49-PLA2 from Bothrops moojeni snake venom, restricts Toxoplasma gondii infection via ROS and VEGF regulation.
Journal: Chemico-biological interactions
Published: November 28, 2024
Prenylated chalcone analog-mediated Inhibition of Toxoplasma gondii growth in human trophoblast cell line and villous explants.
Journal: Scientific reports
Published: November 07, 2024
Galectin-3 plays a key role in controlling infection by Toxoplasma gondii in human trophoblast cells and human villous explants.
Journal: Frontiers in cellular and infection microbiology
Published: July 04, 2024
Copaifera spp. oleoresins control Trypanosoma cruzi infection in human trophoblast cells (BeWo) and placental explants.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 11, 2024
Copaifera spp. oleoresins and two isolated compounds (ent-kaurenoic and ent-polyalthic acid) inhibit Toxoplasma gondii growth in vitro.
Journal: Experimental parasitology
Published: October 23, 2023
Rottlerin impairs early and late steps of Toxoplasma gondii infection in human trophoblast cells and villous explants.
Journal: Chemico-biological interactions
Published: June 30, 2023
Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal-fetal interface.
Journal: Frontiers in immunology
Published: June 21, 2023
Polyalthic acid and oleoresin from Copaifera trapezifolia Hayne reduce Toxoplasma gondii growth in human villous explants, even triggering an anti-inflammatory profile.
Journal: Experimental parasitology
Published: January 18, 2023
Last Updated: 09/26/2026